FI980822A - Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi - Google Patents
Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi Download PDFInfo
- Publication number
- FI980822A FI980822A FI980822A FI980822A FI980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A
- Authority
- FI
- Finland
- Prior art keywords
- skin
- pharmaceutical composition
- active substance
- mucosa
- mucosal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK115095 | 1995-10-12 | ||
PCT/DK1996/000437 WO1997013528A1 (en) | 1995-10-12 | 1996-10-11 | A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
Publications (2)
Publication Number | Publication Date |
---|---|
FI980822A true FI980822A (fi) | 1998-04-09 |
FI980822A0 FI980822A0 (fi) | 1998-04-09 |
Family
ID=8101575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI980822A FI980822A0 (fi) | 1995-10-12 | 1998-04-09 | Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0871489A1 (fi) |
JP (1) | JPH11513393A (fi) |
AU (1) | AU702030B2 (fi) |
CA (1) | CA2231273A1 (fi) |
FI (1) | FI980822A0 (fi) |
NO (1) | NO981633L (fi) |
WO (1) | WO1997013528A1 (fi) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440980B1 (en) | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
JP2001524958A (ja) * | 1997-04-17 | 2001-12-04 | ジーエス ディベロップメント アクティエボラーグ | 新規な液晶をベースとする生物接着性薬剤送出系 |
AU731909B2 (en) | 1997-07-01 | 2001-04-05 | Isis Pharmaceuticals, Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
EP1001747A1 (en) * | 1997-08-09 | 2000-05-24 | Smithkline Beecham Plc | Compositions for nasal administration |
IL129848A (en) * | 1997-09-09 | 2003-04-10 | Select Release L C | Coated particles and methods of making and using same |
SE9703458D0 (sv) * | 1997-09-25 | 1997-09-25 | Pharmacia & Upjohn Ab | Nicotine compositions and methods of formulation thereof |
EP1469009A2 (en) * | 1998-05-21 | 2004-10-20 | Isis Parmaceuticals, Inc. | Compositions and methods for non-parenteral delivery of oligonucleotides |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
GB9827034D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Manchester | Delivery formulation |
CN1368874A (zh) * | 1999-08-06 | 2002-09-11 | 马克斯-德尔布吕克分子医学研究所 | 可植入的生物活性物质储存体 |
EP1239923A2 (en) * | 1999-12-20 | 2002-09-18 | New Pharma Research Sweden AB | Stabilized veterinary compositions comprising more than one antiviral agent |
DE10057769A1 (de) | 2000-11-22 | 2002-05-23 | Beiersdorf Ag | Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen |
SK287423B6 (sk) * | 2001-04-30 | 2010-09-07 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Farmaceuticky účinné uridínové estery, ich použitie, spôsob ich prípravy a farmaceutický prostriedok |
US7439271B2 (en) * | 2001-06-27 | 2008-10-21 | The Gillette Company | Reduction of hair growth |
US20030124196A1 (en) | 2001-08-22 | 2003-07-03 | Susan Weinbach | Pulsatile release compositions and methods for enhanced intestinal drug absorption |
EP1667656A4 (en) * | 2003-09-01 | 2011-12-28 | Mayne Pharma Int Pty Ltd | COMPOSITIONS AND METHODS OF DISTRIBUTING BIOLOGICALLY ACTIVE AGENTS |
US8236292B2 (en) | 2004-06-04 | 2012-08-07 | Camurus Ab | Liquid depot formulations |
EP1812022B1 (en) | 2004-09-28 | 2014-01-15 | Atrium Medical Corporation | Stand-alone film and methods for making the same |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
EP1804717A4 (en) | 2004-09-28 | 2015-11-18 | Atrium Medical Corp | DRUG DELIVERY COATING WHICH CAN BE USED WITH VASCULAR ENDOPROSTHESIS |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9649382B2 (en) | 2005-01-14 | 2017-05-16 | Camurus Ab | Topical bioadhesive formulations |
PL1848403T3 (pl) * | 2005-01-14 | 2010-09-30 | Camurus Ab | Preparaty bioadhezyjne o działaniu miejscowym |
US8920782B2 (en) | 2005-01-14 | 2014-12-30 | Camurus Ab | Topical bioadhesive formulations |
CA2594711C (en) * | 2005-01-14 | 2012-11-06 | Camurus Ab | Somatostatin analogue formulations |
US8871712B2 (en) | 2005-01-14 | 2014-10-28 | Camurus Ab | Somatostatin analogue formulations |
CA2595385C (en) | 2005-01-21 | 2011-01-25 | Camurus Ab | Pharmaceutical lipid compositions |
MX2007014068A (es) * | 2005-05-10 | 2008-02-07 | Novartis Ag | Composiciones farmaceuticas de liberacion modificada de famciclovir. |
WO2006131730A1 (en) | 2005-06-06 | 2006-12-14 | Camurus Ab | Glp-1 analogue formulations |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US8574627B2 (en) | 2006-11-06 | 2013-11-05 | Atrium Medical Corporation | Coated surgical mesh |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
DK2086504T3 (da) | 2006-10-17 | 2014-04-07 | Nuvo Res Inc | Diclofenac-gel |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
GB0711656D0 (en) | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
GB0716385D0 (en) | 2007-08-22 | 2007-10-03 | Camurus Ab | Formulations |
JP5600101B2 (ja) * | 2008-06-09 | 2014-10-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | エアロゾル製剤の特性を決定するためのデバイス及び方法 |
GB0815435D0 (en) | 2008-08-22 | 2008-10-01 | Camurus Ab | Formulations |
US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
EP2498754B1 (en) | 2009-06-25 | 2018-06-06 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Reverse hexagonal mesophases (h ii) and uses thereof |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
AU2013265210B2 (en) | 2012-05-25 | 2016-09-15 | Camurus Ab | Somatostatin receptor agonist formulations |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
EP2877155B1 (en) | 2012-07-26 | 2020-10-28 | Camurus AB | Opioid formulations |
AU2018255510B2 (en) | 2017-04-20 | 2024-05-30 | Zeenar Enterprises Pty Ltd | Liquid crystalline dosage form for administering a statin |
CN112770778A (zh) * | 2018-09-07 | 2021-05-07 | 法纳克斯株式会社 | 含有非层状液晶形成脂质的外用剂 |
EP3870155A4 (en) * | 2018-10-25 | 2023-08-09 | Zeenar Enterprises Pty Ltd | COMPOSITION FOR FORMING LIQUID CRYSTALLINE PARTICLES |
CN111821254B (zh) * | 2019-04-18 | 2021-10-15 | 华东师范大学 | 一种抗病毒水凝胶及其制备方法和应用 |
CN111759858B (zh) * | 2020-06-02 | 2022-09-20 | 杭州英健生物科技有限公司 | pH敏感型消化道粘膜保护胶及其应用 |
CN112791047A (zh) * | 2021-01-15 | 2021-05-14 | 中国人民解放军总医院第三医学中心 | 一种白藜芦醇层状液晶及其制备方法 |
EP4419884A2 (en) * | 2021-10-19 | 2024-08-28 | Sensach AB | Lipid patch |
WO2023189270A1 (ja) * | 2022-03-28 | 2023-10-05 | 富士フイルム株式会社 | 生体用組成物 |
WO2023189273A1 (ja) * | 2022-03-28 | 2023-10-05 | 富士フイルム株式会社 | 生体用組成物 |
WO2024068672A1 (en) * | 2022-09-26 | 2024-04-04 | Universität Bern | Structured lipid compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2631282A1 (de) * | 1976-07-12 | 1978-01-19 | Kali Chemie Pharma Gmbh | Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln |
SE457933B (sv) * | 1987-07-06 | 1989-02-13 | Larsson Kare | Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion |
CA2038744C (en) * | 1990-03-23 | 2002-01-08 | Yoshitomi Pharmaceutical Industries Ltd. | Pharmaceutical composition containing slightly water-soluble drug |
WO1995026715A2 (en) * | 1994-03-30 | 1995-10-12 | Dumex-Alpharma A/S | Use of fatty acid esters as bioadhesive substances |
-
1996
- 1996-10-11 EP EP96934441A patent/EP0871489A1/en not_active Withdrawn
- 1996-10-11 JP JP9514651A patent/JPH11513393A/ja active Pending
- 1996-10-11 AU AU72792/96A patent/AU702030B2/en not_active Ceased
- 1996-10-11 CA CA002231273A patent/CA2231273A1/en not_active Abandoned
- 1996-10-11 WO PCT/DK1996/000437 patent/WO1997013528A1/en not_active Application Discontinuation
-
1998
- 1998-04-08 NO NO981633A patent/NO981633L/no not_active Application Discontinuation
- 1998-04-09 FI FI980822A patent/FI980822A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0871489A1 (en) | 1998-10-21 |
AU702030B2 (en) | 1999-02-11 |
WO1997013528A1 (en) | 1997-04-17 |
JPH11513393A (ja) | 1999-11-16 |
AU7279296A (en) | 1997-04-30 |
CA2231273A1 (en) | 1997-04-17 |
NO981633L (no) | 1998-06-04 |
FI980822A0 (fi) | 1998-04-09 |
NO981633D0 (no) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI980822A0 (fi) | Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi | |
DE69830095D1 (de) | Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe | |
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
NO962606L (no) | Farmasöytisk sammensetning | |
ID24654A (id) | Formulasi farmasi omeprazola | |
BR9607317A (pt) | Peptídios e composição farmacêutica | |
BR9607318A (pt) | Peptidos e composição farmacêutica | |
EE04390B1 (et) | Paikne preparaat dermatoloogiliste seisundite raviks | |
IS5665A (is) | Lyfjafræðileg þrýstiúða samsetning | |
PT907364E (pt) | Composicao farmaceutica de libertacao sustida | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
BR9610396A (pt) | Formulação farmacêutica | |
IT1295645B1 (it) | Apparecchio per l'elettroemanazione di principi attivi. | |
EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
FI964619A0 (fi) | Epilepsialääkkeiden iholle annostelu | |
LV11727A (lv) | Farmaceitiska kompozicija | |
FI973229A0 (fi) | Uusi farmaseuttinen koostumus | |
BR9806083A (pt) | Composi-Æo farmac-utica para o tratamento da hapattite c | |
PT1017388E (pt) | Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca | |
FI973280A (fi) | Farmaseuttinen koostumus | |
TR199600583A2 (tr) | Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi. | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
BR9606066A (pt) | Composto e formulação farmacêutica | |
BR9605777A (pt) | Composição farmacêutica |